Skip to main content
Fig. 2 | BMC Anesthesiology

Fig. 2

From: Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial

Fig. 2

The risk of PPD and cumulative sufentanil consumption up to 48 h postoperatively. A The EPDS scores of patients between the control and esketamine groups. B the incidence of PPD at 42 days after surgery. C cumulative sufentanil consumption up to 48 h postoperatively. Data were presented as mean ± SD. ****Indicates that the scores on the EPDS were significantly lower in the esketamine group than in the control group (P < 0.0001). *Indicates a significant decrease in sufentanil consumption in the esketamine group compared to the control group during 0–24 h, and 0–48 h postoperatively (P < 0.05). PPD, postpartum depression; EPDS, Edinburgh Postnatal Depression Scale

Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us